Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Scientific
MedTech
Boston Scientific sees 70% EP growth after Farapulse launch
“This is the most transformational product that I've seen in my career,” CEO Mike Mahoney said on Boston Scientific’s first-quarter earnings call.
Conor Hale
Apr 25, 2024 10:00am
FTC asks Boston Scientific, Axonics for more info on $3.7B deal
Apr 4, 2024 11:33am
Bos Sci nets first US approval for drug-coated coronary balloon
Mar 1, 2024 1:49pm
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Boston Scientific's Farapulse system nets FDA approval in afib
Jan 31, 2024 11:01am
JPM24: Boston Scientific drops $3.7B on neuromod player Axonics
Jan 8, 2024 10:12am